Site icon fundsforNGOs

Apply for De Boer-van Staveren Fund – Netherlands

RFPs: Smart and Connected Energy Management

Deadline: 15-Jul-2026

The De Boer-van Staveren Fund is accepting applications from early-career scientific researchers conducting innovative research on autoimmune diseases in the Netherlands.

The programme supports independent research projects in biomedical and medical sciences while helping early-career researchers establish their own innovative research lines.

Programme Focus Areas

The fund supports:

The programme particularly encourages innovative and original research approaches related to autoimmune diseases.

Funding Support

Selected researchers may receive:

Number of awards:

The funding supports research-related activities and project development.

Who is Eligible?

Eligible applicants include:

Applicants must:

The four-year eligibility period may be extended under the Academy’s extension arrangement.

Eligibility for PhD Candidates

Researchers in the final stage of their PhD may also apply if:

Research Requirements

Applicants must:

Required Application Documents

Applicants must submit:

Programme Objectives

The initiative aims to:

Tips for Applicants

Strong applications should:

Projects with strong scientific relevance and innovation may receive stronger consideration.

FAQ

How much funding is available?

Researchers may receive up to €50,000 each.

How many researchers are selected?

Up to three researchers are funded annually.

Who can apply?

Early-career researchers in medical, biomedical, or related scientific disciplines.

What is the PhD eligibility limit?

Applicants must normally have completed their PhD within the last four years.

Can final-year PhD candidates apply?

Yes, if they can start the research within three months after receiving the award.

Conclusion

The De Boer-van Staveren Fund supports innovative autoimmune disease research by early-career scientists in the Netherlands. Through funding for independent research projects, the programme helps emerging researchers establish their scientific careers while advancing biomedical knowledge and innovation in autoimmune disease research.

For more information, visit KNAW.

Exit mobile version